advanced search
Michael O'Rourke
President & Founder
Scotia Vision

Is this your profile?

About

Michael O’Rourke is a specialised ophthalmic pharma consultant with expertise in pharmaceutical, drug delivery and medical device strategies.

Contributions

EXPERT VIEW
SUSTAINED RELEASE OCULAR THERAPEUTICS
Michael O’Rourke gives an overview of the current state of the ophthalmics market, going into greater detail on the opportunities offered in the area of sustained-release technologies and therapies.

More contributions

EXPERT VIEW
SUSTAINED-RELEASE OCULAR DELIVERY TECHNOLOGIES
Michael O'Rourke discusses the advances in the development and launching of sustained-release ocular drug delivery systems seen in recent years.
COMPANY SHOWCASE: GRAYBUG
GrayBug is advancing ophthalmic therapeutics through a continuum of polymerbased drug delivery platforms and innovative products offering sustained competitive advantage.
Top

W3 Total Cache is currently running in Pro version Development mode.